Early research (Phase 1)Study completedNCT02586051
What this trial is testing
Obinutuzumab to Evaluate Safety and Tolerability in Hypersensitized Adult Participants With End Stage Renal Disease Awaiting Transplantation
Who this might be right for
Kidney Failure, Chronic
Hoffmann-La Roche 24